| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.00074 | 1 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.0007 | 1 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.0003 | 1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.00023 | 1 |